10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2017 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2017 10-K (Filed: Feb 14, 2018) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | |
| Cash flows from operating activities: | |||
| Cash receipts from customers | $ 176,594 | 172,310 | 148,954 |
| Cash paid for inventory and prescriptions dispensed by retail network pharmacies | (149,279) | (142,511) | (122,498) |
| Cash paid to other suppliers and employees | (15,348) | (15,478) | (14,035) |
| Interest received | 21 | 20 | 21 |
| Interest paid | (1,072) | (1,140) | (629) |
| Income taxes paid | (2,909) | (3,060) | (3,274) |
| Net cash provided by operating activities | 8,007 | 10,141 | 8,539 |
| Cash flows from investing activities: | |||
| Purchases of property and equipment | (1,918) | (2,224) | (2,367) |
| Proceeds from sale-leaseback transactions | 265 | 230 | 411 |
| Proceeds from sale of property and equipment and other assets | 33 | 37 | 35 |
| Acquisitions (net of cash acquired) and other investments | (1,287) | (539) | (11,475) |
| Purchase of available-for-sale investments | (86) | (65) | (267) |
| Maturity of available-for-sale investments | 61 | 91 | 243 |
| Net cash used in investing activities | (2,932) | (2,470) | (13,420) |
| Cash flows from financing activities: | |||
| Increase (decrease) in short-term debt | (598) | 1,874 | (685) |
| Proceeds from issuance of long-term debt | 3,455 | 14,805 | |
| Repayments of long-term debt | (5,943) | (2,902) | |
| Purchase of noncontrolling interest in subsidiary | (39) | ||
| Payment of contingent consideration | (26) | (58) | |
| Dividends paid | (2,049) | (1,840) | (1,576) |
| Proceeds from exercise of stock options | 329 | 296 | 362 |
| Payments for taxes related to net share settlement of equity awards | (71) | (72) | (63) |
| Repurchase of common stock | (4,361) | (4,461) | (5,001) |
| Other | (1) | (5) | (3) |
| Net cash provided by (used in) financing activities | (6,751) | (6,761) | 4,879 |
| Effect of exchange rate changes on cash and cash equivalents | 1 | 2 | (20) |
| Net increase (decrease) in cash and cash equivalents | (1,675) | 912 | (22) |
| Cash and cash equivalents at the beginning of the period | 3,371 | 2,459 | |
| Cash and cash equivalents at the end of the period | 1,696 | 3,371 | 2,459 |
| Reconciliation of net income to net cash provided by operating activities: | |||
| Net income | 6,623 | 5,319 | 5,239 |
| Adjustments required to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 2,479 | 2,475 | 2,092 |
| Goodwill impairment | 181 | ||
| Losses on settlement of defined benefit pension plans | 187 | ||
| Stock-based compensation | 234 | 222 | 230 |
| Loss on early extinguishment of debt | 643 | 0 | |
| Deferred income taxes | (1,334) | 18 | (252) |
| Other noncash items | 53 | 135 | (14) |
| Change in operating assets and liabilities, net of effects from acquisitions: | |||
| Accounts receivable, net | (941) | (243) | (1,594) |
| Inventories | (514) | (742) | (1,141) |
| Other current assets | (341) | 35 | 355 |
| Other assets | 3 | (43) | 2 |
| Accounts payable and claims and discounts payable | 1,710 | 2,189 | 2,834 |
| Accrued expenses | (371) | 131 | 892 |
| Other long-term liabilities | 38 | 2 | (104) |
| Net cash provided by operating activities | 8,007 | 10,141 | 8,539 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2017 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |